Blueberries Medical Corp (1OA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Blueberries Medical Corp (1OA) has a cash flow conversion efficiency ratio of -0.114x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-107.92K) by net assets (€942.86K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Blueberries Medical Corp - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Blueberries Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Blueberries Medical Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Blueberries Medical Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tracsis Plc
LSE:TRCS
|
0.106x |
|
CT UK High Income Ord
LSE:CHI
|
0.025x |
|
Sobr Safe Inc
NASDAQ:SOBR
|
-0.338x |
|
TinOne Resources Inc
V:TORC
|
-0.045x |
|
Tongyang Inc
KO:001527
|
-0.001x |
|
Lucibel
PA:ALUCI
|
6.802x |
|
Earthwise Minerals Corp.
F:966
|
0.089x |
|
Trifast plc
LSE:TRI
|
0.049x |
Annual Cash Flow Conversion Efficiency for Blueberries Medical Corp (2016–2024)
The table below shows the annual cash flow conversion efficiency of Blueberries Medical Corp from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €834.81K | €-796.85K | -0.955x | -39.39% |
| 2023-12-31 | €1.95 Million | €-1.33 Million | -0.685x | +31.56% |
| 2022-12-31 | €1.47 Million | €-1.47 Million | -1.001x | +14.57% |
| 2021-12-31 | €1.43 Million | €-1.68 Million | -1.171x | -90.59% |
| 2020-12-31 | €3.89 Million | €-2.39 Million | -0.614x | -15.57% |
| 2019-12-31 | €8.08 Million | €-4.29 Million | -0.532x | -401.59% |
| 2017-12-31 | €-70.38K | €-12.41K | 0.176x | -46.81% |
| 2016-12-31 | €-314.91K | €-104.38K | 0.331x | -- |
About Blueberries Medical Corp
Blueberries Medical Corp. engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia. The company produces psychoactive and non-psychoactive cannabis derivatives. It also distributes functional supplements, wellness products, and natural ingredients. Blueberries Medical Corp. is based in Vancouver, Canada.